Yahoo Web Search

Search results

  1. 3 days ago · TOKYO, Oct. 9, 2024 /PRNewswire/ -- Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, 'Ciconia') today announced its establishment as a joint venture company based on a master agreement signed on April 22, 2024 by Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO, Christophe Weber, 'Takeda'), Astellas Pharma Inc. (TSE: 4503, President ...

  2. 3 days ago · The general pharmaceutical market’s growth is attributed to improvements in the drug review and approval process, which are expected to incentivise the sector’s manufacturers to introduce their products in the country. “It is now required that all medicine packaging includes generic names to enhance transparency and affordability for ...

  3. 2 days ago · Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (collectively, Teva) have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). Teva, headquartered in Parsippany, New Jersey, is the largest generic drug manufacturer in the United States.

  4. 2 days ago · ROCKVILLE, Md., Oct. 10, 2024 /PRNewswire/ -- Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ...

  5. 5 days ago · GlaxoSmithKline, Novartis and Sanofi are among the largest foreign pharmaceutical companies doing business in the Philippines. Among domestic drug companies, United Laboratories, Pascual...

  6. 3 days ago · Humanwell Pharmaceutical US Inc. has synthesized new sigma non-opioid intracellular receptor 1 (SIGMAR1) antagonists reported to be useful for the treatment of cancer, pain, psychosis and substance abuse and dependence.

  7. 5 days ago · From 6 February to 15 March 2024, the FDA inspected the pharmaceutical manufacturing facility of Wittman Pharma, Inc. in Brooksville and found violations of Current Good Manufacturing Practices (CGMP) for finished drug products, which led to a number of quality risks for the manufactured products.